Biosion

Developer of antibody-based therapeutics to treat various diseases

placeNanjing, Jiangsu, China calendar_todayFounded 2017 groups90 employees language biosion.com

Social engagement

Social engagement: 1.2K social following, 9 posts in the last 12 months — below the industry typical range.

Investor mix

9 investors on record; lead investors include Oceanpine Capital, Zheshang Innovation Investment Group, 3E BioVentures, GF Xinde Investment Management.

Investor typeCountShare
Venture capital556%
Private equity333%
Angel & family office111%

Recent activity

18 Jun 2026
Event
BIOCHINA Global Forum & Biopharmaceutical Bioprocess Development (BPD) Summit
15 Jun 2026
Product launch
FlipiBody® Platform
3 Jun 2026
Event
World Bispecific & TCE Summit South Korea
Coming soon